Literature DB >> 11468149

Simultaneous fetal cell identification and diagnosis by epsilon-globin chain immunophenotyping and chromosomal fluorescence in situ hybridization.

M Choolani1, H O'Donnell, C Campagnoli, S Kumar, I Roberts, P R Bennett, N M Fisk.   

Abstract

Isolating fetal erythroblasts from maternal blood offers a promising noninvasive alternative for prenatal diagnosis. The current immunoenzymatic methods of identifying fetal cells from background maternal cells postenrichment by labeling gamma-globin are problematic. They are nonspecific because maternal cells may produce gamma-globin, give poor hybridization efficiencies with chromosomal fluorescence in situ hybridization (FISH), and do not permit simultaneous visualization of the fetal cell identifier and the FISH signal. We describe a novel technique that allows simultaneous visualization of fetal erythroblast morphology, chromosomal FISH, and epsilon-globin labeled with AMCA (7-amino-4-methylcoumarin-3-acetic acid). AMCA was chosen as the fluorescent label to circumvent the problem of heme autofluorescence because the mean difference in relative fluorescence intensity between fetal erythroblasts stained positive for antiglobin antibody and autofluorescence of unstained cells was greater with AMCA (mean 43.2; 95% confidence interval [CI], 34.6-51.9; SD = 14.0) as the reporting label compared with fluorescein isothiocyanate (mean 24.2; 95% CI, 16.4-31.9; SD = 12.4) or phycoerythrin (mean 9.8; 95% CI, 4.8-14.8; SD = 8.0). Median FISH hybridization efficiency was 97%, comparable to the 98% (n = 5 paired samples) using Carnoy fixative. One epsilon-positive fetal erythroblast was identified among 10(5) maternal nucleated cells in 6 paired mixture experiments of fetal erythroblasts in maternal blood (P <.001). Male epsilon-positive fetal erythroblasts were clearly distinguishable from adult female epsilon-negative erythroblasts, with no false positives (n = 1000). The frequency of fetal erythroblasts expressing epsilon-globin declines linearly from 7 to 14 weeks' gestation (y = -15.8 x + 230.8; R(2) = 0.8; P <.001). We describe a rapid and accurate method to detect simultaneously fetal erythroblast morphology, intracytoplasmic epsilon-globin, and nuclear FISH. (Blood. 2001;98:554-557)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11468149     DOI: 10.1182/blood.v98.3.554

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

Review 1.  Recent developments in fetal medicine.

Authors:  Sailesh Kumar; Anna O'Brien
Journal:  BMJ       Date:  2004-04-24

Review 2.  Overview and recent developments in cell-based noninvasive prenatal testing.

Authors:  Liesbeth Vossaert; Imen Chakchouk; Roni Zemet; Ignatia B Van den Veyver
Journal:  Prenat Diagn       Date:  2021-05-18       Impact factor: 3.242

3.  Epsilon haemoglobin specific antibodies with applications in noninvasive prenatal diagnosis.

Authors:  Morten Draeby Sørensen; Regina Gonzalez Dosal; Kim Bak Jensen; Britta Christensen; Steen Kølvraa; Uffe Birk Jensen; Peter Kristensen
Journal:  J Biomed Biotechnol       Date:  2009-07-14

4.  Evidence for feasibility of fetal trophoblastic cell-based noninvasive prenatal testing.

Authors:  Amy M Breman; Jennifer C Chow; Lance U'Ren; Elizabeth A Normand; Sadeem Qdaisat; Li Zhao; David M Henke; Rui Chen; Chad A Shaw; Laird Jackson; Yaping Yang; Liesbeth Vossaert; Rachel H V Needham; Elizabeth J Chang; Daniel Campton; Jeffrey L Werbin; Ron C Seubert; Ignatia B Van den Veyver; Jackie L Stilwell; Eric P Kaldjian; Arthur L Beaudet
Journal:  Prenat Diagn       Date:  2016-10-02       Impact factor: 3.050

Review 5.  Isolation and Enrichment of Circulating Fetal Cells for NIPD: An Overview.

Authors:  Giulia Sabbatinelli; Donatella Fantasia; Chiara Palka; Elisena Morizio; Melissa Alfonsi; Giuseppe Calabrese
Journal:  Diagnostics (Basel)       Date:  2021-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.